Cargando…

Early differentiation of neurodegenerative diseases using the novel QSM technique: what is the biomarker of each disorder?

During neurodegenerative diseases, the brain undergoes morphological and pathological changes; Iron deposits are one of the causes of pathological changes in the brain. The Quantitative susceptibility mapping (QSM) technique, a type of magnetic resonance (MR) image reconstruction, is one of the newe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nikparast, Farzaneh, Ganji, Zohreh, Zare, Hoda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336059/ https://www.ncbi.nlm.nih.gov/pubmed/35902793 http://dx.doi.org/10.1186/s12868-022-00725-9

Ejemplares similares

Brain pathological changes during neurodegenerative diseases and their identification methods: How does QSM perform in detecting this process?
por: Nikparast, Farzaneh, et al.
Publicado: (2022)

Systematic Review: Quantitative Susceptibility Mapping (QSM) of Brain Iron Profile in Neurodegenerative Diseases
por: Ravanfar, Parsa, et al.
Publicado: (2021)

QSM is an imaging biomarker for chronic glial activation in multiple sclerosis lesions
por: Gillen, Kelly M., et al.
Publicado: (2021)

Iterative Restoration of the Fringe Phase (REFRASE) for QSM
por: Lindemeyer, Johannes, et al.
Publicado: (2021)

Incomplete spectrum QSM using support information
por: Fuchs, Patrick, et al.
Publicado: (2023)

Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker
por: Wang, Yi, et al.
Publicado: (2015)

In Vivo Quantitative Susceptibility Mapping (QSM) in Alzheimer's Disease
por: Acosta-Cabronero, Julio, et al.
Publicado: (2013)

Feasibility of quantitative susceptibility mapping (QSM) of the human kidney
por: Bechler, Eric, et al.
Publicado: (2020)

Ironsmith: An automated pipeline for QSM-based data analyses
por: Zachariou, Valentinos, et al.
Publicado: (2022)

Quantitative susceptibility mapping (QSM) evaluation of infantile neuroaxonal dystrophy
por: Fujiwara, Takuya, et al.
Publicado: (2019)

Correction to: Feasibility of quantitative susceptibility mapping (QSM) of the human kidney
por: Bechler, Eric, et al.
Publicado: (2021)

HFP‐QSMGAN: QSM from homodyne‐filtered phase images
por: Beliveau, Vincent, et al.
Publicado: (2022)

Quantitative susceptibility mapping (QSM) of the cardiovascular system: challenges and perspectives
por: Aimo, Alberto, et al.
Publicado: (2022)

Dynamic contrast-enhanced QSM for perfusion imaging: a systematic comparison of ΔR2*- and QSM-based contrast agent concentration time curves in blood and tissue
por: Lind, Emelie, et al.
Publicado: (2020)

Early Biomarkers of Neurodegenerative and Neurovascular Disorders in Diabetes
por: Gasecka, Aleksandra, et al.
Publicado: (2020)

Automatic Detection of Focal Cortical Dysplasia Type II in MRI: Is the Application of Surface-Based Morphometry and Machine Learning Promising?
por: Ganji, Zohreh, et al.
Publicado: (2021)

LAILAPS-QSM: A RESTful API and JAVA library for semantic query suggestions
por: Chen, Jinbo, et al.
Publicado: (2018)

Comparison of T(2)*-weighted and QSM contrasts in Parkinson's disease to visualize the STN with MRI
por: Alkemade, Anneke, et al.
Publicado: (2017)

The Effect of Deep Learning-Based QSM Magnetic Resonance Imaging on the Subthalamic Nucleus
por: Liu, Yuanqin, et al.
Publicado: (2021)

MP2RAGEME: T(1), T(2) (*), and QSM mapping in one sequence at 7 tesla
por: Caan, Matthan W. A., et al.
Publicado: (2018)

Retracted: The Effect of Deep Learning-Based QSM Magnetic Resonance Imaging on the Subthalamic Nucleus
por: Healthcare Engineering, Journal of
Publicado: (2023)

Effects of aging on [Formula: see text] , [Formula: see text] , and QSM MRI values in the subcortex
por: Keuken, M. C., et al.
Publicado: (2017)

Quantitative susceptibility mapping (QSM) and R2(*) of silent cerebral infarcts in sickle cell anemia
por: Murdoch, Russell, et al.
Publicado: (2022)

Reviews on biomarker studies in psychiatric and neurodegenerative disorders
por: Guest, Paul C
Publicado: (2019)

Circulating miRNAs as Biomarkers for Neurodegenerative Disorders
por: Grasso, Margherita, et al.
Publicado: (2014)

Epigenetic Biomarkers as Diagnostic Tools for Neurodegenerative Disorders
por: Martínez-Iglesias, Olaia, et al.
Publicado: (2021)

Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study
por: Langkammer, Christian, et al.
Publicado: (2012)

The Quality Sequencing Minimum (QSM): providing comprehensive, consistent, transparent next generation sequencing data quality assurance
por: Mahamdallie, Shazia, et al.
Publicado: (2018)

An illustrated comparison of processing methods for MR phase imaging and QSM: combining array coil signals and phase unwrapping
por: Robinson, Simon Daniel, et al.
Publicado: (2016)

Decompose quantitative susceptibility mapping (QSM) to sub-voxel diamagnetic and paramagnetic components based on gradient-echo MRI data
por: Chen, Jingjia, et al.
Publicado: (2021)

Biomarkers in neurodegenerative disorders: translating research into clinical practice
por: Menéndez-González, Manuel
Publicado: (2014)

Plasma biomarkers for neurodegenerative disorders: ready for prime time?
por: Balogun, Wasiu G., et al.
Publicado: (2023)

What Can Oral Prophylaxis and Orthodontia Do for Each Other?
por: Hoff, N. S.
Publicado: (1909)

Noninvasive quantification of oxygen saturation in the portal and hepatic veins in healthy mice and those with colorectal liver metastases using QSM MRI
por: Finnerty, Eoin, et al.
Publicado: (2018)

Multi-centre, multi-vendor reproducibility of 7T QSM and R(2)* in the human brain: Results from the UK7T study
por: Rua, Catarina, et al.
Publicado: (2020)

Bioelemental patterns in the cerebrospinal fluid as potential biomarkers for neurodegenerative disorders
por: Maass, Fabian, et al.
Publicado: (2018)

Resting-state connectivity in neurodegenerative disorders: Is there potential for an imaging biomarker?
por: Hohenfeld, Christian, et al.
Publicado: (2018)

Unified framework for brain connectivity-based biomarkers in neurodegenerative disorders
por: Kim, Sung-Woo, et al.
Publicado: (2022)

Olfactory dysfunction as a common biomarker for neurodegenerative and neuropsychiatric disorders
por: Slabik, David, et al.
Publicado: (2022)

Salivary Biomarkers: Future Approaches for Early Diagnosis of Neurodegenerative Diseases
por: Schepici, Giovanni, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_92397eage24kb3s0scsk3t8h0f